1. The subject of the contract is the delivery of various medicines according to 3 packages to the headquarters of the Ordering Party (Krakow, Złota Jesieni 1), in accordance with the description and requirements contained in Annex 1 to nin. Specification. 2. Expiry date / warranty period of the subject of the order: it may not be shorter than 12 months from the date of delivery, and for enteral and oral nutrition products – not shorter than half of the expiry date for a given product. 3. In drug and chemotherapy programmes, only drugs included in the NFZ reimbursement lists are allowed (the price of the drug may not exceed the financing limit set by the NFZ). 4. By including the form of the drug in the specification, e.g. tabl. He means all kinds of pills, and Kaps. all types of capsules, etc. In other cases, the exact form of the drug is determined, i.e. tablet. enteric, i.e. only an enteric tablet is allowed. 5. A medicinal product constituting the subject of the order should be understood as medicinal products within the meaning of the Pharmaceutical Law Act of 6 September 2001 (consolidated text: Journal of Laws of 2022, item 2301, as amended). The offered medicinal product must be authorized for marketing on the terms set out in Article 3 or 4 paragraphs 1 and 2 or 4a of the Pharmaceutical Law. 6. The Ordering Party, in the execution of this order in the part concerning the transport of the medicinal product to the headquarters of the Ordering Party, allows the participation of subcontractors with authorizations. 7. The remaining terms of the contract are specified in the draft contract, constituting Annex 3 to the Specification.

International name/ Description of the medicinal product Dose/ parameter Form/ package Number of packages/ pcs/ mg Unit PACKAGE 1 1 Faricimabum 28.8mg/0.24ml solution for injection 50 vials

PL *PACKAGE 2 1 Tafasitamabum 200mg powder for concentrate for solution for infusion 500 vial *Drug used in the Drug Program, the amount of consumption depends on the number of patients who can be qualified for treatment, in accordance with the guidelines of the drug program

PL * PACKAGE 3 1 Azacitidinum 200mg a 7pcs tabl. coated 60 pack of 2 300mg and 7 pcs 100 *The drug used in the Drug Program, the amount of consumption depends on the number of patients who can be qualified for treatment, in accordance with the guidelines of the drug program